PharmaCyte Biotech

PMCBNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$6.335 M

$0.59 +0.00%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$19.4M

Loss-making

Shares outstanding

10,735,649

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#152CurisCRIS$7.83M
#153Liminatus PharmaLIMN$6.92M
#154PharmaCyte BiotechPMCB$6.34M
#155BioAtlaBCAB$5.74M
#156BiomXPHGE$4.25M

Where these numbers come from

Share counts and financials for PharmaCyte Biotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.